FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032358900> ?p ?o ?g. }

• W2032358900 endingPage "563" @default.
• W2032358900 startingPage "554" @default.
• W2032358900 abstract "CD95 (Fas/Apo-1)-mediated apoptosis was shown to occur through two distinct pathways. One involves a direct activation of caspase-3 by large amounts of caspase-8 generated at the DISC (Type I cells). The other is related to the cleavage of Bid by low concentration of caspase-8, leading to the release of cytochrome c from mitochondria and the activation of caspase-3 by the cytochrome c/APAF-1/caspase-9 apoptosome (Type II cells). It is also known that the protein synthesis inhibitor cycloheximide (CHX) sensitizes Type I cells to CD95-mediated apoptosis, but it remains contradictory whether this effect also occurs in Type II cells. Here, we show that sub-lethal doses of CHX render both Type I and Type II cells sensitive to the apoptogenic effect of anti-CD95 antibodies but not to chemotherapeutic drugs. Moreover, Bcl-2-positive Type II cells become strongly sensitive to CD95-mediated apoptosis by the addition of CHX to the cell culture. This is not the result of a restraint of the anti-apoptotic effect of Bcl-2 at the mitochondrial level since CHX-treated Type II cells still retain their resistance to chemotherapeutic drugs. Therefore, CHX treatment is granting the CD95-mediated pathway the ability to bypass the mitochondria requirement to apoptosis, much alike to what is observed in Type I cells." @default.
• W2032358900 created "2016-06-24" @default.
• W2032358900 creator A5008007021 @default.
• W2032358900 creator A5015327368 @default.
• W2032358900 creator A5018927818 @default.
• W2032358900 creator A5033120586 @default.
• W2032358900 creator A5035001405 @default.
• W2032358900 creator A5036372037 @default.
• W2032358900 creator A5050705314 @default.
• W2032358900 date "2008-02-01" @default.
• W2032358900 modified "2023-10-01" @default.
• W2032358900 title "Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide" @default.
• W2032358900 cites W1480948328 @default.
• W2032358900 cites W1492606093 @default.
• W2032358900 cites W1593219141 @default.
• W2032358900 cites W1836073275 @default.
• W2032358900 cites W1920633728 @default.
• W2032358900 cites W1968120167 @default.
• W2032358900 cites W1973109581 @default.
• W2032358900 cites W1974129037 @default.
• W2032358900 cites W1978587144 @default.
• W2032358900 cites W1979066737 @default.
• W2032358900 cites W1979129905 @default.
• W2032358900 cites W1982294781 @default.
• W2032358900 cites W1983645982 @default.
• W2032358900 cites W1985224552 @default.
• W2032358900 cites W1985856659 @default.
• W2032358900 cites W1991300200 @default.
• W2032358900 cites W1992310350 @default.
• W2032358900 cites W2012173926 @default.
• W2032358900 cites W2013515819 @default.
• W2032358900 cites W2038114873 @default.
• W2032358900 cites W2042409437 @default.
• W2032358900 cites W2052788415 @default.
• W2032358900 cites W2062853648 @default.
• W2032358900 cites W2076807689 @default.
• W2032358900 cites W2094124526 @default.
• W2032358900 cites W2095578202 @default.
• W2032358900 cites W2110925122 @default.
• W2032358900 cites W2119352514 @default.
• W2032358900 cites W2119683782 @default.
• W2032358900 cites W2135416318 @default.
• W2032358900 cites W2159650080 @default.
• W2032358900 cites W2160224004 @default.
• W2032358900 cites W2162653594 @default.
• W2032358900 cites W2169491517 @default.
• W2032358900 doi "https://doi.org/10.1016/j.yexcr.2007.11.003" @default.
• W2032358900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18078929" @default.
• W2032358900 hasPublicationYear "2008" @default.
• W2032358900 type Work @default.
• W2032358900 sameAs 2032358900 @default.
• W2032358900 citedByCount "9" @default.
• W2032358900 countsByYear W20323589002012 @default.
• W2032358900 countsByYear W20323589002013 @default.
• W2032358900 countsByYear W20323589002014 @default.
• W2032358900 countsByYear W20323589002015 @default.
• W2032358900 countsByYear W20323589002022 @default.
• W2032358900 crossrefType "journal-article" @default.
• W2032358900 hasAuthorship W2032358900A5008007021 @default.
• W2032358900 hasAuthorship W2032358900A5015327368 @default.
• W2032358900 hasAuthorship W2032358900A5018927818 @default.
• W2032358900 hasAuthorship W2032358900A5033120586 @default.
• W2032358900 hasAuthorship W2032358900A5035001405 @default.
• W2032358900 hasAuthorship W2032358900A5036372037 @default.
• W2032358900 hasAuthorship W2032358900A5050705314 @default.
• W2032358900 hasConcept C153911025 @default.
• W2032358900 hasConcept C163421366 @default.
• W2032358900 hasConcept C190283241 @default.
• W2032358900 hasConcept C193349765 @default.
• W2032358900 hasConcept C2775998712 @default.
• W2032358900 hasConcept C2778128677 @default.
• W2032358900 hasConcept C28859421 @default.
• W2032358900 hasConcept C29311851 @default.
• W2032358900 hasConcept C3031857 @default.
• W2032358900 hasConcept C31573885 @default.
• W2032358900 hasConcept C3675279 @default.
• W2032358900 hasConcept C55493867 @default.
• W2032358900 hasConcept C86803240 @default.
• W2032358900 hasConcept C95444343 @default.
• W2032358900 hasConcept C98424977 @default.
• W2032358900 hasConceptScore W2032358900C153911025 @default.
• W2032358900 hasConceptScore W2032358900C163421366 @default.
• W2032358900 hasConceptScore W2032358900C190283241 @default.
• W2032358900 hasConceptScore W2032358900C193349765 @default.
• W2032358900 hasConceptScore W2032358900C2775998712 @default.
• W2032358900 hasConceptScore W2032358900C2778128677 @default.
• W2032358900 hasConceptScore W2032358900C28859421 @default.
• W2032358900 hasConceptScore W2032358900C29311851 @default.
• W2032358900 hasConceptScore W2032358900C3031857 @default.
• W2032358900 hasConceptScore W2032358900C31573885 @default.
• W2032358900 hasConceptScore W2032358900C3675279 @default.
• W2032358900 hasConceptScore W2032358900C55493867 @default.
• W2032358900 hasConceptScore W2032358900C86803240 @default.
• W2032358900 hasConceptScore W2032358900C95444343 @default.
• W2032358900 hasConceptScore W2032358900C98424977 @default.
• W2032358900 hasIssue "3" @default.
• W2032358900 hasLocation W20323589001 @default.
• W2032358900 hasLocation W20323589002 @default.

• next